“INNOVATION IN HEALTHCARE: FROM

TECHNOLOGY TO BUSINESS MODELS

AND TRANSACTIONS”

A Joint Event - Swiss HLG & PLCF Summer Conference 16th May 2018, 9am-5pm

Novartis Campus, Basel (Switzerland)

A Joint Event - Swiss HLG & PLCF Summer Conference, 16th May 2018

Preliminary Program 9:00am - 5:00pmWelcome Note • Gabrielle Gache, President Swiss HLG• Philippe Rozo, President Pharma Licensing Club France• Nigel Sheail, Head of M&A and BD&L at Novartis Featured Speakers and Program• Patrick Aebischer – President emeritus, Brain Mind Institute at EPFL (Keynote Speaker)• Jurgi Camblong –Co-Founder and Chief Executive Officer at Sophia Genetics• Hervé Affagard – Co-Founder and Chief Executive Officer at MaaT Pharma• Panel* around Financing – Moderator: Marc Ceulemans• Vas Narasimhan - Chief Executive Officer at Novartis • Networking Lunch (Buffet/Standing)• Mondher Mahjoubi - Chief Executive Officer at Innate Pharma• Patrick Amstutz – Co-Founder and Chief Executive Officer at Molecular Partners

*Panelists - “Financing” Michèle Ollier, Partner at Medicxi Christoph Kausch, Founding Partner and Chief Executive Officer at MTIPBervin Bouani, Senior Investment Manager at Turenne Capital Marie Petit, Principal at Villiger ValuationJean-Philippe Tripet, Managing Partner at AravisModerator: Marc Ceulemans, Head Strategic Venture Capital Fund at Novartis

Registration cost: including Networking Lunch & BreaksSwiss HLG Member and PLCF Member Rate € 130

Non-Member Rate € 150the number of seats/attendees is limited, register now!

TO REGISTER >> https://swisshlg.ngaevents.co.uk/swisshlg-basel/Use public transport as parking availability is very limited on Novartis Campus

(map will be provided once registration completed)

This conference is not only an excellent platform for networking with colleagues but also a good place to showcase and attract partners to your organization.

For more information and contact details : www.swisshlg.com

“INNOVATION IN HEALTHCARE: FROM TECHNOLOGY TO

BUSINESS MODELS AND TRANSACTIONS”